ABSTRACT NUMBER: ESOC2026A2166 METABOLIC SIGNATURES DISTINGUISHING SMALL-VESSEL FROM ATHEROTHROMBOTIC ISCHEMIC STROKE: AN EXPLORATORY ANALYSIS Authors: Ylenia Avivar Saez, Daniel Caraballo Mata, Joan Isern Cabrero, Laia Seró, Antoni Suarez, Anaïs Bertran Lavisier, Cristina Vargas Catalán, Josep Ribalta Vives, Alan Flores, Xavier Ustrell Roig Published: 2026 ABSTRACT AbstractBackground and aimsAtherothrombotic and small-vessel ischemic stroke are physiopathologically distinct, yet differences in their systemic metabolic and inflammatory signatures remain poorly defined. This exploratory study examined whether metabolomic and inflammatory markers differ between these two etiologies.MethodsWe conducted a cross-sectional analysis including patients with atherothrombotic stroke (n=22) or small-vessel stroke (n=10). Metabolomic variables (amino acids, energy-related metabolites, lipid subclasses) and inflammatory markers (blood cell counts, NLR, CRP, Glyc-A/B/F) were evaluated at admission. Separate linear regression models were fitted for each variable, adjusting for age, sex, diabetes mellitus type 2 and dyslipidaemia; the atherothrombotic subtype served as reference. Statistical significance was defined as p < 0.05.ResultsThree metabolites showed significantly higher levels in the small-vessel group: glutamate (β = +50.7, p = 0.0096), lactate (β = +443.9, p = 0.0320), and threonine (β = +30.3, p = 0.0449). No inflammatory biomarker demonstrated significant differences. The concurrent increase in glutamate, lactate and threonine may reflect a coordinated metabolic shift involving glycolytic acceleration, mitochondrial strain and enhanced amino-acid turnover, although causality cannot be inferred in this exploratory context. Interpretation is constrained by the small sample size, cross-sectional design, limited covariate adjustment and the absence of longitudinal metabolic profiling.ConclusionsThis analysis identifies a potential metabolic signature distinguishing small-vessel from atherothrombotic stroke, while inflammatory markers showed no discriminatory value. Larger, longitudinal studies are required to validate these preliminary findings.Conflict of interestNo conflicts of interest for any authorFigure 1 - belongs to Results